Dossier d`information Euro Pharmat
Contents
1. Conseils D Utilisation 1 D rouler environ 30 cm de bande et rel cher la tension de celle ci 2 Sans tirer la bande effectuer un tour complet et recouvrir d un second tour Presser doucement la surface pour assurer une bonne tenue 3 Poursuivre le bandage en maintenant la tension n cessaire pour obtenir la compression souhait e Toujours relacher la bande apr s l avoir d roul e avant de l appliquer afin de ne pas exercer une tension trop forte 4 Une fois l application termin e couper l exc dent de bande Une l g re pression de la main sur le bandage assure une bonne tenue 4 8 Entrez PubMed Annexe 4 Page 1 of 4 National By gt NCBI PubW ed evnar K Entrez PubMed Nucleotide Protein Genome Structure OMIM PMC Journals Search PubMed x for coban compression Go Clear M Limits Preview Index History Clipboard Dete About Entrez Display Abstract M Show 20 Sort x Sendto f Text Version Entrez PubMed Overview Help FAQ Tutorial New Noteworthy E Utilities PubMed Services Journals Database MeSH Database Single Citation Matcher Batch Citation Matcher Clinical Queries LinkOut Cubby Related Resources Order Documents NLM Gateway TOXNET Consumer Health Clinical Alerts ClinicalTrials gov PubMed Central Privacy Policy http www ncbi nlm nih gov entrez query fegi CMD Display amp DB pubmed Items 1 5 of 5 M 1 Lymphology 2002 Ma2. and shallow PFCs were redu of ulcers treated with DD UB versus 40 of ulcers treated with UB alpl No other significant differences in inflammation histopathology or capil frequency were observed CONCLUSIONS Treatment with DD UB red in twice the number of ulcers than UB alone in 1 week This is the first sc documentation that a topical wound dressing could reduce the pathophysi associated with venous ulcers beyond the known beneficial effect of grac http www ncbi nlm nih gov entrez query fcgi CMD Display amp DB pubmed 06 05 2004 6 8 Entrez PubMed Page 3 of 4 compression Not all hydrocolloid dressing are fibrinolytic so this effect generalize to other dressings Publication Types e Clinical Trial PMID 8486467 PubMed M 4 J Vasc Surg 1992 Mar 15 3 480 6 Related Comment in e J Vasc Surg 1992 Sep 16 3 500 1 J Vasc Surg A prospective randomized trial of Unna s boot versus Duode hydroactive dressing plus compression in the management of leg ulcers Cordts PR Hanrahan LM Rodriguez AA Woodson J LaMorte WY Menzoian JO Section of Vascular Surgery Boston University School of Medicine MA Leg ulcers caused by chronic venous insufficiency plague an estimated 5 Americans but there have been few improvements in conservative treatrr century and Unna s boot continues to be a mainstay of therapy A recent suggests that Duoderm CGF dressing provides greater patient comfort an compliance but Duoderm alone wi
3. blood flow and sub pressure reductions The implications of the present findings for venous v therapy are speculative and based on the concept that arterial pulsatile flo augmentation is a positive feature If so more frequent bandage changes transient flow stimulation or use of bandages to better maintain sub band pressure to sustain flow increases may be useful PMID 9568350 PubMed M 3 Int J Dermatol 1993 Apr 32 4 304 6 Related Fibrin cuff lysis in chronic venous ulcers treated with a hydr dressing Mulder G Jones R Cederholm Williams S Cherry G Ryan T Wound Healing Institute Denver Colorado 80014 BACKGROUND Pericapillary fibrin cuffs PFC are a recognized part c pathology of venous stasis ulcers A hydrocolloid dressing capable of lys surface fibrin was tested in venous ulcers for its capacity to lyse pericapil below the wound surface METHODS Tissue biopsies from the rims of ulcers were evaluated for thickness of shallow and deep dermal PFCs bef after treatment with DuoDERM covered by Unna s boot and a compressic DD UB n 9 versus the same treatment without the hydrocolloid dres 10 Frozen sections of all biopsies were stained with an immunofluore antibody to fibrin for rating of PFC thickness Separate sections were stai hematoxylin and eosin to assess capillary frequency histopathology and inflammation All ratings and pathology assessments were performed blir treatment conditions RESULTS Both deep
4. du latex Fibres de polyester non tiss es li es avec un copolym re acrylique Fibres lastiques longitudinales en spandex Substance coh sive base de caoutchouc naturel et de composants sp cifiques hypoallerg niques e Caract ristiques physiques Allongement Longitudinal 125 Transversal 24 Charge minimale de rupture Longitudinale 1 430 g cm Transversale 1 200 g cm M V T R 7000 g m2 24h e Tests de biocompatibilit Pr sence de latex e Date d expiration du produit et conservation 5 ans dans des conditions de stockage normales soit une temp rature moyenne de 10 C 30 C avec 30 60 HR e Mode de st rilisation possible La bande coh sive 3M Coban existe en version st rile 2 8 Elimination des d chets Incin ration e Lieu de fabrication 3M Medical Manufacturing Kamen Germany Edisonstrasse 6 59157 Kamen Germany III Pr sentations commerciales e H pital Identification Code Num ro d ms Rouleaux identification Boites re brown 1581 DH 9999 7880 1 30 Coban chair brown 1582 DH 9999 7881 9 Coban chair brown 1583 DH 9999 7882 7 Coban chair i ess ON Coban chair brown 1584 L DH 09978850 100 6 18 goban chair prown Rte RTS 100 EE Coban bleu i 1584 B DH 9999 7892 6 10 18 SE AAN ee Coban blanc white 6910 DH 9999 7921 3 Coban blanc white 6910 DH 9999 7926 2 3 8 Annexe 2
5. Assoc 1972 Jun 10 65 11 290 3 Related The use of Coban bandages in compression sclerotherapy Kline AL Fegan WG Publication Types e Clinical Trial e Controlled Clinical Trial PMID 5030910 PubMed Display Abstract Items 1 5 of 5 Write to the Help Desk NCBI NLM NIH Department of Health amp Human Services Freedom of Information Act Disclaimer M 8 8
6. Dossier d information Euro Pharmat DISPOSITIF MEDICAL Nom Laboratoires 3M Sant D nomination commune Bande Coh sive Contention Nom commercial 3M Coban avec ou sans latex st rile ou non st rile 4 Conditions de conservation et de stockage Conditions normales de conservation amp de stockage 10 C a 30 C avec 30 a 60 HR Pr cautions particulieres non applicable Dur e de la validit du produit 5 ans dans des conditions de stockage normales Pr sence d indicateurs de temp rature s il y a lieu non applicable 5 S curit d utilisation S curit technique le cas ch ant renvoyer la notice d utilisation ou notice d information Pour les DM implantables passage possible a l IRM radiod tectabilit S curit biologique s il y a lieu 6 Conseils d utilisation Mode d emploi Annexe 2 Indications destination marquage CE La bande 3M Coban est concue pour la r alisation de compressions de contentions ainsi que pour le maintien de pansements et attelles Pr cautions d emploi Se rapporter la notice en annexe s il y a lieu Le coban avec latex ne doit jamais tre mis sur un patient allergique au latex directement sur une plaie ouverte Toujours d rouler 20 30 cm de bande avant d tre appliqu e Doit tre pos e avec la tension souhait e car la bande ne se d tend pas apr s application V rifier que la compression exerc e est sans danger p
7. ng edema reduction which however exceeded rebound swelling basis MLD on the other hand showed a steady gradual daily decline in PMID 11939569 PubMed Iv 2 Clin Physiol 1998 Mar 18 2 117 24 Full text blackwell lt synengy com pes tunes Compression induced pulsatile blood flow changes in human Related Mayrovitz HN 06 05 2004 5 8 Entrez PubMed Page 2 of 4 Miami Heart Research Institute Miami Beach Florida 33140 USA Initial and sustained 7 h impacts of foot to knee compression bandagin arterial pulsatile blood flow were assessed by nuclear magnetic resonance in eight healthy supine subjects A widely used bandaging method zinc i gauze Coban and a slight variant Coban only were applied one week one leg Blood flow was measured on each day of bandage application be after bandaging and after 7 h of normal activity Initial mean sub bandage lateral gaiter were between 28 4 and 28 9 mmHg but were significantly after 7 h to 16 3 19 4 mmHg Overall below knee pulsatile blood perfusic initially significantly increased by both methods mainly due to increased blood flow Bandaging was also associated with a decrease in blood perft nonbandaged control leg mainly due to a decrease in distal blood flow N these effects were sustained after 7 h The fact that neither sub bandage p blood flow was sustained may indicate a causal linkage a concept consis the finding of a linear relationship between afternoon
8. our le patient effet garrot c est dire qu il faut v rifier que la peau est non d color e non refroidie sans troubles sensitifs fourmillement Contre Indications Ce produit n est pas con u pour d autres usages que ceux indiqu s Absolues et relatives Se rapporter la notice en annexe sil y a lieu 7 Informations compl mentaires sur le produit Bibliographie rapport d essais cliniques ou d tudes pharmaco conomiques am lioration du service rendu recommandations particuli res d utilisation restrictions de prise en charge technique qualification de l op rateur etc Voir annexe 4 8 Liste des annexes au dossier s il y a lieu 1 8 Annexe 1 Laboratoires 3M Sant Boulevard de Oise A j 95029 Cergy Pontoise Cedex T l 01 30 31 58 44 Fax 01 30 31 85 51 Fiche Technique 3M Coban Marquage CE Classe I non st rile Bande de contention lastique coh sive avec ou sans latex I Indications La bande lastique coh sive 3M Coban est une bande concue pour la contention en traumatologie b nigne en phl bologie en m decine du sport et pour le maintien de pansements ou de dispositifs m dicaux II Caract ristiques du produit La bande 3M Coban est perm able l air et l eau mais ne perd pas ses caract ristiques au contact de l eau car elle est hydrophobe 1l existe une version st rile e Composition contient
9. r 35 1 23 7 Related Erratum in e Lymphology 2002 Jun 35 2 96 Limb volume reduction after physical treatment by compres and or massage in a rodent model of peripheral lymphedema Kriederman B Myloyde T Bernas M Lee Donaldson L Preciado S Stea B Summers P Witte C Witte M Department of Surgery The University of Arizona Tucson 85724 5063 lymph u arizona edu Lack of a standardized experimental counterpart of peripheral lympheden small animal has hampered research into treatment of this debilitating cor recently refined a rodent model consisting of radical unilateral lymphatic excision in conjunction with a circumferential integumental gap followe regional irradiation of the groin to reproduce stable unilateral hindlimb L current study Wistar Fuzzy rats with established right hindlimb LE were subdivided into five groups and subjected to one of the following daily p regimens over a 5 day period pneumatic compression pumping at 30 tor low stretch multi layered compressive bandaging using Coban CB mar lymphedema drainage MLD or a light massage consisting of stationary motions using the fingertips combined physiotherapy CPT consisting of CB and a no treatment or control group CTRL Hindlimb and LE volu serially measured before and after treatment Whereas CTRL showed pro worsening of hindlimb swelling PCP CB CPT and MLD each produced and substantial edema reduction over the 5 day interval PCP CB and CP vacillati
10. thout compression resulted in slowe1 compared with Unna s boot We enrolled 30 patients 30 ulcers in a clini compare Duoderm CGF plus compression Coban wrap to Unna s boot significant difference was observed between the two groups with respect initial ulcer area ulcer duration or extent of venous insufficiency by dup Eight of 16 ulcers 50 in the Duoderm group healed completely versus ulcers 43 in the Unna s boot group p 0 18 Healing rates square ct per week correlated significantly with initial ulcer area and initial ulcer f for both groups but best correlated with initial ulcer perimeter r 0 88 w Duoderm p less than 0 0001 r 0 80 with Unna s boot p less than 0 002 adjusting for differences in initial ulcer perimeter healing rates were sign faster for patients on Duoderm than patients on Unna s boot during the fir of therapy 0 384 0 059 cm2 wk cm perimeter for Duoderm versus 0 0 043 cm2 wk cm perimeter for Unna s boot p 0 002 At 12 weeks pat Duoderm again appeared to heal faster than those on Unna s boot althous did not reach statistical significance 0 049 0 007 cm2 wk cm perimet Duoderm versus 0 020 0 017 for Unna s boot p 0 11 ABSTRACT TRUNCATED AT 250 WORDS Publication Types e Clinical Trial e Randomized Controlled Trial PMID 1538504 PubMed http www ncbi nlm nih gov entrez query fcgi CMD Display amp DB pubmed 06 05 2004 7 8 Entrez PubMed Page 4 of 4 5 J Ir Med
Download Pdf Manuals
Related Search